ShockOmics: multiscale approach to the identification of molecular biomarkers in acute heart failure induced by shock

Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine
Federico AlettiGiuseppe Baselli

Abstract

The ShockOmics study (ClinicalTrials.gov identifier NCT02141607) is a multicenter prospective observational trial aimed at identifying new biomarkers of acute heart failure in circulatory shock, by means of a multiscale analysis of blood samples and hemodynamic data from subjects with circulatory shock. Ninety septic shock and cardiogenic shock patients will be recruited in three intensive care units (ICU) (Hôpital Erasme, Université Libre de Bruxelles, Belgium; Hospital Universitari Mutua Terrassa, Spain; Hôpitaux Universitaires de Genève, Switzerland). Hemodynamic signals will be recorded every day for up to seven days from shock diagnosis (time T0). Clinical data and blood samples will be collected for analysis at: i) T1 < 16 h from T0; ii) T2 = 48 h after T0; iii) T3 = day 7 or before discharge or before discontinuation of therapy in case of fatal outcome; iv) T4 = day 100. The inclusion criteria are: shock, Sequential Organ Failure Assessment (SOFA) score > 5 and lactate levels ≥ 2 mmol/L. The exclusion criteria are: expected death within 24 h since ICU admission; > 4 units of red blood cells or >1 fresh frozen plasma transfused; active hematological malignancy; metastatic cancer; chronic immunodepression; pre-existing end...Continue Reading

References

Feb 1, 1995·The Journal of Trauma·A SauaiaP T Pons
May 1, 1993·Archives of Surgery·S R ShackfordP L Wolf
Jul 10, 1998·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·Y M YaoG Schlag
Apr 23, 1999·European Heart Journal·M R CowieG C Sutton
Jan 17, 2002·The New England Journal of Medicine·E RiversUNKNOWN Early Goal-Directed Therapy Collaborative Group
Apr 18, 2003·The New England Journal of Medicine·Greg S MartinMarc Moss
Feb 27, 2004·Intensive Care Medicine·Marc Moss, Gregory S Martin
Jun 22, 2006·Endocrine, Metabolic & Immune Disorders Drug Targets·Derek C AngusEliezer Silva
Apr 24, 2007·Heart Failure Reviews·François AllaGerasimos Filippatos
Apr 25, 2007·Critical Care Medicine·Alain Rudiger, Mervyn Singer
Dec 7, 2007·The American Journal of Medicine·James M O'BrienEdward Abraham
Feb 6, 2008·Circulation·Harmony R Reynolds, Judith S Hochman
Nov 5, 2008·Annals of Internal Medicine·Raban V JegerUNKNOWN AMIS Plus Registry Investigators
Dec 19, 2008·Critical Care : the Official Journal of the Critical Care Forum·Lilian MinneEvert de Jonge
Apr 23, 2009·Microcirculation : the Official Journal of the Microcirculatory Society, Inc·Geert W Schmid-Schönbein
Jul 28, 2009·Current Opinion in Critical Care·Sergio L Zanotti-Cavazzoni, Steven M Hollenberg
Mar 5, 2010·The New England Journal of Medicine·Daniel De BackerUNKNOWN SOAP II Investigators
Oct 27, 2010·Annals of the New York Academy of Sciences·Edwin A Deitch
Aug 28, 2012·The New England Journal of Medicine·Holger ThieleUNKNOWN IABP-SHOCK II Trial Investigators
Jan 25, 2013·Science Translational Medicine·Frank A DeLanoGeert W Schmid-Schönbein
Jan 29, 2013·Critical Care Medicine·R Phillip DellingerUNKNOWN Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup
Oct 11, 2013·JAMA : the Journal of the American Medical Association·Andrea MorelliMervyn Singer
Nov 1, 2013·The New England Journal of Medicine·Jean-Louis Vincent, Daniel De Backer
Mar 19, 2014·The New England Journal of Medicine·Pietro CaironiUNKNOWN ALBIOS Study Investigators
Mar 19, 2014·The New England Journal of Medicine·Donald M YealyDerek C Angus
Oct 2, 2014·The New England Journal of Medicine·Sandra L PeakePatricia Williams
Mar 18, 2015·The New England Journal of Medicine·Paul R MounceyUNKNOWN ProMISe Trial Investigators

❮ Previous
Next ❯

Citations

Mar 28, 2019·Clinics·Renato Teixeira SouzaUNKNOWN Preterm SAMBA Study Group
Dec 21, 2019·Critical Care : the Official Journal of the Critical Care Forum·Daniele BragaCristina Barlassina
Nov 23, 2018·Critical Care : the Official Journal of the Critical Care Forum·Matteo BarcellaCristina Barlassina
Sep 10, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Elisa MaffioliGabriella Tedeschi
Aug 3, 2021·Journal of Cardiac Surgery·Shaoyuan ChenPeiyi Xie
Oct 20, 2018·British Journal of Anaesthesia·J Bauzá-MartinezE de Oliveira

❮ Previous
Next ❯

Clinical Trials Mentioned

NCT02141607

Software Mentioned

ShockOmics
RASS
ixTrend Professional
- hem
SAS
Better Care
NOTOCORD

Related Concepts

Related Feeds

Cardiogenic Shock

Cardiogenic shock is a devastating consequence of acute myocardial infarction and is associated with an extremely high mortality. Here is the latest research.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.